Dr. Matthew Blake Lockwood, MD

  • Springdale, AR
  • Hematologist and oncologist
NPI1265875470PAC ID0749507895
Medicare services, 2024
242,753
Medicare patients, 2024
1,547
Part D claims, 2024
3,148
Publications
2
Clinical trials
1
Practice address
3901 Parkway Cir, Springdale, AR 72762
Practice phone
Call (479) 587-1700
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Highlands Oncology Group PA

Springdale, Arkansas

See all 8 affiliations

Find Dr. Lockwood's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Matthew Blake Lockwood is a hematologist and oncologist in Springdale, Arkansas

Dr. Lockwood practices at Highlands Oncology Group PA in Springdale, Arkansas.

Dr. Lockwood's NPI, 1265875470, was assigned on April 8, 2013. Dr. Lockwood graduated from University of Arkansas College of Medicine in 2013. Dr. Lockwood holds Arkansas license E-9626.

NPI and contact details
Medicare PAC ID
0749507895
NPI enumeration date
April 8, 2013
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(479) 587-1700
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
39
Medical school graduation
2013

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Matthew Blake Lockwood practices at Highlands Oncology Group PA in Springdale, Arkansas

Dr. Lockwood's primary practice is Highlands Oncology Group PA, at 3901 Parkway Cir, Springdale, AR 72762 in Washington County. The practice phone is (479) 587-1700.

  • Highlands Oncology Group PA
    3901 Parkway Cir, Springdale, AR 72762 · Washington CountyPhone(479) 587-1700

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Matthew Blake Lockwood is affiliated with 7 sites of care and 1 medical group

Dr. Lockwood's primary practice is Highlands Oncology Group PA in Springdale, Arkansas. Dr. Lockwood is also affiliated with Freeman Health System - Springdale Medical Center. The medical group on file is Highlands Oncology Group. Dmand AI also links Dr. Lockwood to 3 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

See all 8 affiliations for Dr. Lockwood

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Matthew Blake Lockwood's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lockwood practices, 6 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Highlands Oncology Group PAAvailable with a free account
+6 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Lockwood practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Matthew Blake Lockwood is one of 89 hematologists and oncologists in Arkansas

Hematology and oncology is Dr. Lockwood's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Lockwood is licensed in Arkansas.

Specialties and state licenses

  • Hematology and oncology, ArkansasPrimaryLicense E-9626 · taxonomy 207RH0003X

Hematologists and oncologists near Dr. Lockwood

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Matthew Blake Lockwood billed Medicare for 242,753 services in 2024

CMS data shows 242,753 Medicare services from Dr. Lockwood across 128 procedure codes in 2024, for 1,547 Medicare patients. Medicare paid $4,030,877 for them.

Medicare services, 2024242,753
Medicare patients1,547
Paid by Medicare$4M
Procedure codes128

Dr. Lockwood's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 142,6342024: 125,91712%
Other services
2023: 117,9752024: 89,59224%
Lab and pathology
2023: 20,0582024: 20,2941%
Tests and treatments
2023: 4,1842024: 3,42718%
Office and hospital visits
2023: 2,3302024: 2,2663%
Imaging
2023: 8272024: 1,09332%
Surgery
2023: 1,0192024: 16484%

Where Dr. Lockwood's Medicare services took place, 2024

  • In an office242,555100%
  • In a facility1980%

Dr. Lockwood compared with the Arkansas median for hematologists and oncologists, 2024

  • Dr. Lockwood
  • Arkansas median
Medicare services
242,753vs 4,81650.4 times
Medicare patients
1,547vs 7582.0 times
Part D claims
2,707vs 1,1732.3 times

Medians across 88 hematologists and oncologists in Arkansas with Dmand AI profiles that report each measure.

Dr. Lockwood's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Lockwood

Need commercial claims for Dr. Lockwood?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Lockwood and other hematologists and oncologists in Arkansas.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Matthew Blake Lockwood treated 1,547 Medicare patients in 2024, average age 74

CMS counts 1,547 Medicare patients who saw Dr. Lockwood in 2024. The largest group is 65 to 74, with 677 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.22, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lockwood's median patient age at 69, with 51% women.

Medicare patients, 20241,547
Average age74
Average risk score2.22
Also on Medicaid7%

Dr. Lockwood's Medicare patients by age, 2024

Dr. Lockwood's Medicare patients by sex, 2024

  • Women78050%
  • Men76750%

Chronic conditions among Dr. Lockwood's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol69%
  3. Arthritis48%
  4. Cancer48%
  5. Ischemic heart disease36%
  6. Chronic kidney disease32%
  7. Anxiety30%
  8. Diabetes30%

Share of Medicare patients with each condition. A patient can have several.

Dr. Lockwood's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 69

Patient panel by sex, all payers

  • Women51%
  • Men49%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Matthew Blake Lockwood wrote 3,148 Medicare Part D claims in 2024

In 2024, Dr. Lockwood wrote 3,148 Medicare Part D claims for 482 patients. 81% of them were for generic drugs. CMS names the drug for 2,707 of them, across 74 drugs with 11 or more claims each, at $4,848,877 in total drug cost. In 2023, CMS named 2,257 claims across 59 drugs.

Part D claims, 20243,148
Drugs named by CMS74
Total drug cost$4.8M
Part D patients482

Dr. Lockwood's Part D claims by kind of drug, 2024

  • Generic2,564 claims81%
  • Brand-name and other584 claims19%

Dr. Lockwood's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Lockwood's Part D claims, 2024

  • Opioids8%251 of 3,148 claims
  • Antibiotics5%164 of 3,148 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 2,2572024: 2,70720%

Drugs named by CMS: 74 in 2024, 59 in 2023.

See all prescribing by Dr. Lockwood

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Matthew Blake Lockwood scored 91 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Lockwood for performance year 2024, reported as part of a group. Dr. Lockwood accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lockwood as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Lockwood's MIPS scores, performance year 2024

  • 91of 100Final score
  • 86.4of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 75of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Lockwood by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Matthew Blake Lockwood has 2 publications on record

Dmand AI links 2 papers to Dr. Lockwood, published from 2015 to 2019. Dr. Lockwood's most frequent co-authors are Rajesh Banderudrappagari, MD and Issam Makhoul, MD.

Papers2
Years published2015 to 2019

Dr. Lockwood's most frequent co-authors

Recent publications by Dr. Lockwood

See all 2 publications and co-authors

See who Dr. Lockwood researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Lockwood works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Matthew Blake Lockwood has worked on 1 clinical trial

Dmand AI links Dr. Lockwood to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Neoplasm Metastasis and Neoplastic Processes. Open Payments lists research payments to Dr. Lockwood that name 1 trial.

Conditions in Dr. Lockwood's trials

  • Neoplasm Metastasis
  • Neoplastic Processes

Investigators on the most trials with Dr. Lockwood

Recent clinical trials with Dr. Lockwood

Sources: Open Payments (CMS), 2025 data, released July 7, 2026; Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Matthew Blake Lockwood received $7,924 in industry payments from 2019 to 2025

CMS Open Payments shows 406 general payments to Dr. Lockwood from 62 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 74% of the total. Bristol-Myers Squibb Company paid the most, $1,369. It also lists 1 research payment totaling $31,749 in 2022, naming 1 clinical trial.

General payments to Dr. Lockwood by program year, 2019 to 2025

General payments to Dr. Lockwood by kind, 2019 to 2025

$7.9Kin total
  • Food and beverage$5,86274%
  • Consulting fees$1,96425%
  • Education$991%

Companies that paid Dr. Lockwood the most, 2019 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Lockwood

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Matthew Blake Lockwood graduated from University of Arkansas College of Medicine

Dr. Lockwood graduated from University of Arkansas College of Medicine in 2013.

  1. Medical schoolUniversity of Arkansas College of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Matthew Blake Lockwood's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Matthew Blake Lockwood

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Matthew Blake Lockwood's NPI number?

Dr. Matthew Blake Lockwood's NPI number is 1265875470. It was assigned on April 8, 2013, and it is active in the NPI Registry.

What kind of doctor is Dr. Matthew Blake Lockwood?

Dr. Matthew Blake Lockwood is a hematologist and oncologist in Springdale, Arkansas. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Matthew Blake Lockwood practice?

Dr. Lockwood practices at 3901 Parkway Cir, Springdale, AR 72762. Dr. Lockwood's primary practice is Highlands Oncology Group PA in Springdale, Arkansas. Dmand AI also links Dr. Lockwood to 3 hospitals, 1 group practice or clinic and 1 home health agency.

What is Dr. Matthew Blake Lockwood's office phone number?

The practice phone on file for Dr. Lockwood is (479) 587-1700.

What is Dr. Matthew Blake Lockwood's medical license number?

Dr. Lockwood holds Arkansas license E-9626.

Which hospitals is Dr. Matthew Blake Lockwood affiliated with?

Dr. Lockwood is affiliated with Freeman Health System - Springdale Medical Center. Dmand AI links Dr. Lockwood to 3 more hospitals.

What medical group is Dr. Matthew Blake Lockwood part of?

Dr. Lockwood is linked to Highlands Oncology Group.

Does Dr. Matthew Blake Lockwood accept Medicare?

Yes. CMS data shows Dr. Lockwood billed Medicare for 242,753 services in 2024, and Dr. Lockwood accepts Medicare assignment.

Does Dr. Matthew Blake Lockwood offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Lockwood as offering telehealth services.

What is Dr. Matthew Blake Lockwood's MIPS score?

Dr. Lockwood's MIPS final score for performance year 2024 is 91 out of 100, reported as part of a group.

Show 8 more questionsShow fewer questions

How many Medicare patients does Dr. Matthew Blake Lockwood see?

CMS counts 1,547 Medicare patients who saw Dr. Lockwood in 2024, with an average age of 74.

What services does Dr. Matthew Blake Lockwood bill to Medicare?

In 2024, Dr. Lockwood's most billed Medicare services were medicare temporary code (Q9967), injected or infused drug (J9299) and injected or infused drug (J9271).

Where did Dr. Matthew Blake Lockwood go to medical school?

Dr. Lockwood graduated from University of Arkansas College of Medicine in 2013.

What drugs does Dr. Matthew Blake Lockwood prescribe most?

In 2024 Medicare Part D data, Dr. Lockwood's most prescribed drugs by claims were Prednisone, Ondansetron ODT and Oxycodone HCl.

Has Dr. Matthew Blake Lockwood received payments from drug or device companies?

CMS Open Payments shows $7,924 in general payments to Dr. Lockwood from 62 companies from 2019 to 2025. The largest total came from Bristol-Myers Squibb Company.

How long has Dr. Matthew Blake Lockwood been practicing?

Dr. Lockwood graduated from medical school in 2013, 13 years ago.

Does Dr. Matthew Blake Lockwood do research?

Dmand AI links 2 publications to Dr. Lockwood, published from 2015 to 2019. Dr. Lockwood has worked on 1 clinical trial.

Who does Dr. Matthew Blake Lockwood publish with?

Dr. Lockwood's most frequent co-authors are Rajesh Banderudrappagari, MD (1 shared paper) and Issam Makhoul, MD (1 shared paper).

Selling to hematology and oncology practices?

See hematologists and oncologists in Arkansas by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)